Drug Information Association Logo

DIA Hosts Webinar in Collaboration with Cytel

WASHINGTON — Dec 4, 2013

When Outsourcing Stops Making Sense 

DIA, on December 4, will host the next meeting in its Solution Provider educational webinar series – this one being held in cooperation with Cytel: When Outsourcing Stops Making Sense.

Cytel is collaborating with DIA to participate in its Solution Provider Webinar Program. DIA’s educational collaboration with Cytel brings together leading scientists and thought leaders from industry who will host this webinar.  

Register today for the no-charge December 4 webinar to learn from experts:
Steve Herbert Sr. Vice President, Cytel Inc., United States
Darren Abrams Recent Vice President, Corporate Development, Ximedica, United States

All Solution Provider webinars are free to all featuring topics including oncology, strategies for late phase development, biomarkers and technology as an enabler of clinical development services.

Susan Cantrell, Director, North America at DIA said, “The Solution Provider series has been enormously successful in disseminating vital information to a great number of people. We are excited to host what will prove to be another insightful and in depth discussion with Cytel – this one an examination of how to avoid flawed outsourced relationships not only in clinical operations, but especially in overseas clinical support functions, including biostatistics, statistical programming and data handling.

Cytel’s Steve Herbert said, “We look forward to examining, with DIA, the shifting global economic trends that compel outsourcing of highly-skilled, clinical support functions, exploring the top reasons most outsourcing initiatives disappoint and the necessity of establishing contingency plans for when outsourcing stops making sense.”



ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.

ABOUT CYTEL: The clinical development of drugs and devices is a crucial contribution to human welfare. We stand committed to improving the success rates of the clinical development process through the application of statistical science and innovative technology.

All 25 leading global pharmaceutical, biotech and medical device companies rely on Cytel when planning and implementing their clinical studies. Pioneers in adaptive trials, every adaptive design submitted for regulatory review has been deemed acceptable.